Scoping review questions | Population (P) | Concept (C) | Context (C) |
---|---|---|---|
1. What have been the changes of the provision of healthcare services for the care of people living with RNDs in Europe during COVID-19 pandemic? | People living with rare neurological diseases and neurometabolic disorders in Europe | Organization of healthcare services provision | COVID-19 pandemic |
2. What measures (like telemedicine and digital e-tools, etc.) have been implemented for the mitigation of disruption or discontinuity of care for people with RNDs in Europe during COVID-19 pandemic? | People with RNDs and neurometabolic disorders in Europe | Telemedicine and digital e-tools such as Electronic Health Records (HER), etc. | Disruption or discontinuity of care during COVID-19 pandemic |